(Q43243148)

17 November 2017

title

Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate (English)

1 reference

17 November 2017

1

Eugene R Bleecker

1 reference

17 November 2017

4

Jonathan Corren

1 reference

17 November 2017

Harold S Nelson

2

1 reference

17 November 2017

Monica Kraft

3

1 reference

17 November 2017

Deborah A Meyers

5

1 reference

17 November 2017

Steven W Yancey

6

1 reference

17 November 2017

Wayne H Anderson

7

1 reference

17 November 2017

Amanda H Emmett

8

1 reference

17 November 2017

Hector G Ortega

9

1 reference

17 November 2017

language of work or name

English

0 references

publication date

12 November 2009

1 reference

American Journal of Respiratory and Critical Care Medicine

17 November 2017

published in

1 reference

17 November 2017

volume

181

1 reference

17 November 2017

issue

7

1 reference

17 November 2017

page(s)

676-687

1 reference

Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

Association between bronchodilating response to short-acting beta-agonist and non-synonymous single-nucleotide polymorphisms of beta-adrenoceptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

Sequence, haplotype, and association analysis of ADRbeta2 in a multiethnic asthma case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

Interactive effects between polymorphisms in the beta-adrenergic receptors and longitudinal changes in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

ADRB2 Arg16Gly polymorphism, lung function, and mortality: results from the Atherosclerosis Risk in Communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

Regular inhaled beta-agonist treatment in bronchial asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

The use of beta-agonists and the risk of death and near death from asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

End of the New Zealand asthma mortality epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

beta-Adrenergic receptor polymorphisms and response to salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

Pharmacogenetics and asthma: false hope or new dawn?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

Spirometric reference values from a sample of the general U.S. population

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

Score tests for association between traits and haplotypes when linkage phase is ambiguous

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

The predictive power of haplotypes in clinical response

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

Variable-length poly-C tract polymorphisms of the beta2-adrenergic receptor 3'-UTR alter expression and agonist regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

ADRB2 polymorphisms and β2 agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

Association between β2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2F200809-1511OC

21 January 2018

Identifiers

DOI

10.1164/200809-1511OC

1 reference

17 November 2017

1 reference